神經血管導管市場規模、佔有率和趨勢分析 |全球| 2026–2032 | 包括導絲引導微導管、血流導引微導管及其他1種產品

2025年全球神經血管導管市場規模約12億美元。預計該市場將以2%的複合年成長率成長，到2032年達到14億美元。

本報告涵蓋導絲引導微導管、血流導引微導管和神經血管引導管。報告定量分析了各公司的銷售量、平均售價、市場規模、成長率和市場佔有率，並包含截至2022年的歷史數據和截至2032年的預測數據。

受人口結構變化和微創血管內手術日益普及的推動，神經血管導管的銷售額預計將穩定成長。在醫療資源和基礎設施不斷改善的開發中地區，成長動能將更為強勁；而在已開發市場，由於神經血管介入治療的基礎設施已趨於飽和，預計銷售額將保持整體穩定。

在預測期內，由於持續的價格壓力和競爭環境，平均售價預計將會下降，即使銷售成長，整體市場規模擴張也可能受到限制。這一趨勢反映出市場已趨於成熟，但仍在穩步發展：技術進步和市場准入的提升推動了銷售成長，而商業性競爭則限制了定價權。

市場概覽

• 全球神經血管導管市場是血管內神經血管介入治療的基礎，為將器械、栓塞劑和治療藥物輸送到腦內目標血管提供了必要的路徑工具。該市場包含三種不同的導管類型：導絲引導式（OTW）微導管，用於在彎曲的解剖結構內精確輸送器械；血流導向式微導管，利用血流來建立通路；以及導引引導管，為微導管系統提供近端支撐和通路。這些產品支持多種手術，包括動脈瘤治療、動靜脈畸形（AVM）栓塞以及缺血性中風治療。

神經系統疾病治療領域從開放性手術轉向血管內治療是推動市場成長的主要因素。由於血管內治療對患者的創傷較小，且與手術夾閉等方法相比，訓練有素的介入獸醫更容易操作，因此，血管內治療在動脈瘤和動靜脈畸形（AVM）的治療中越來越受歡迎。這一趨勢導致每年進行的導管介入手術總數增加，並且所有三種器械類別的需求都在成長。某些類型的動脈瘤目前仍只能透過手術治療，這自然限制了可採用血管內導管介入治療的病例數。

科技進步不斷拓展血管內神經血管手術的可能性。微導管變得越來越小巧、更容易置入，使得醫生能夠進入以往難以到達的大腦區域。物理性能的提升，例如更高的柔韌性和更便捷的插入，使得器械和藥物能夠更精準地輸送到遠端目標。隨著影像技術的精準度不斷提高和應用日益廣泛，動脈瘤和動靜脈畸形（AVM）的診斷率也在不斷提高，擴大了確診患者群體，並推動了手術數量的穩定成長。

區域趨勢影響著市場成長的分佈。隨著醫療基礎設施的改善和介入神經放射學治療的普及，亞太、拉丁美洲和中東等發展中地區的銷售額預計將出現最顯著的成長。同時，北美和西歐等已開發市場基本上保持穩定，較高的基準滲透率限制了需求成長。由於競標和集中競標，平均售價（ASP）在兩種市場類型中都面臨下行壓力，與銷售成長相比，市場價值成長通用。

市場促進因素

對血管內治療的偏好

血管內治療作為外科手術的替代方案，其日益普及是神經血管導管市場的主要驅動力。由於血管內治療創傷較小、患者較安全，且通常比動脈瘤夾閉術等外科手術恢復時間較短，因此用於治療動脈瘤和動靜脈畸形（AVM）的血管內治療越來越普遍。隨著這種臨床偏好不斷增強並被更多醫生和醫療機構接受，需要更多的導管來支持日益成長的手術量。此外，隨著血管內治療的適應症範圍擴大，涵蓋更多種類的動脈瘤和疾病，適合接受導管治療的患者群體也在不斷擴大，這將支撐預測期內銷售額的持續成長。

技術進步

介入導航設備的科技進步在動靜脈畸形（AVM）和動脈瘤的血管內治療領域中發揮了核心作用。導管導引線操控性的提升、微導管的進一步小型化和柔韌性增強，以及導管置入的便捷性，使得導管能夠到達以往產品無法觸及的腦部區域。隨著影像技術的精準度不斷提高和應用範圍的擴大，動脈瘤和AVM的診斷率預計將持續上升，因此需要開展更多基於導管的介入治療來滿足日益成長的患者需求。更小巧、更強大的導管平台的持續研發有望減少外科手術的需求，並進一步加速血管內治療的普及。

市場限制

介入獸醫短缺

能夠進行血管內神經介入手術的合格介入神經放射學醫師數量有限。這些手術需要醫師接受多年的專業訓練和豐富的經驗，才能安全可靠地完成。合格介入醫師數量的不足限制了某些市場中依賴導管介入手術的總量，從而限制了手術量的成長，無論患者需求或技術發展如何。預計合格介入神經放射學醫師數量的增加將直接促進微導管的使用。因此，擴大培訓計畫的覆蓋範圍和血管內治療的轉診途徑對於該市場的長期發展至關重要。

對外科手術的偏見

儘管血管內介入治療在神經外科領域日益普及，但許多資深神經外科醫生仍然習慣於他們職業生涯中屢獲成功的傳統開放性手術技術。此外，不熟悉血管內介入治療優勢的醫生不太可能將患者轉診至導管介入治療，這進一步限制了那些仍以外科手術為主導的醫療機構的病例數。隨著接受過血管內介入治療培訓的年輕醫生進入該領域，以及支持微創神經血管治療臨床獲益的證據不斷積累，這一阻礙因素因素有望逐漸緩解。然而，在目前的預測期內，它仍可能成為某些地區和臨床機構手術量成長速度的重要阻礙因素。

目錄

調查方法

• 第一步：專案推出與團隊組建
• 步驟二：資料系統開發與二次調查實施
• 步驟三：準備面試設計問卷
• 第四步：進行初步調查
• 第五步：調查與分析：估計值基準估計
• 第六步：市場預測與分析
• 第七步：辨識策略機遇
• 步驟 8：最終確認和市場公告
• 步驟九：客戶回饋與市場監測

全球關稅的影響

神經血管導管市場

• 執行摘要
  • 全球神經血管導管市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 神經血管導管市場
  • 導絲式微導管市場
  • 流導微導管市場
  • 神經血管引導管市場
• 促進因素和抑制因素
  • 市場促進因素
  • 市場限制因素
• 競爭性市佔率分析

附錄

The global neurovascular catheter market was valued at approximately $1.2 billion in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 2%, reaching $1.4 billion by 2032.

This report covers over-the-wire microcatheters, flow-directed microcatheters, and neurovascular guiding catheters. The report quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.

Neurovascular catheter unit volumes are expected to rise steadily, driven by demographic trends and the expanding use of minimally invasive endovascular procedures. Growth will be stronger in developing regions as healthcare access and infrastructure improve, while developed markets remain largely stable due to saturation of the interventional neurovascular treatment base.

Continued pricing pressure and competitive dynamics are expected to reduce ASPs over the forecast period, constraining overall market value expansion even as unit volumes grow. This dynamic reflects a mature but steadily evolving market, where technology advancement and access expansion drive volume while commercial competition limits pricing power.

Market Overview

• The global neurovascular catheter market serves as the foundation of endovascular neurovascular intervention, providing the access tools required to deliver devices, embolic agents, and therapies to target vessels within the brain. The market spans three distinct catheter types: over-the-wire microcatheters used for precise device delivery in tortuous anatomy, flow-directed microcatheters that navigate using blood flow, and guiding catheters that provide proximal support and access for microcatheter systems. Together these products support a broad range of procedures including aneurysm treatment, AVM embolization, and ischemic stroke intervention.

The ongoing shift from open surgical methods to endovascular approaches for neurological conditions is the central growth dynamic in this market. Endovascular treatment for aneurysms and AVMs has become more widely preferred over surgical techniques such as clipping, because the procedure is less invasive for the patient and typically simpler to execute for trained interventionalists. This trend increases the total number of catheter-dependent procedures performed each year, expanding unit demand across all three device categories. Some aneurysm types remain amenable only to surgical treatment, which defines a natural ceiling on the share of cases that can be directed toward endovascular catheter-based approaches.

Technological advancement is continuously expanding what is achievable within endovascular neurovascular procedures. Microcatheters are becoming smaller and easier to deploy, capable of navigating regions of the brain that were previously inaccessible. Improved physical properties, including better trackability and pushability, allow more precise delivery of devices and agents to distal targets. As imaging technology becomes more accurate and more widely available, diagnosis rates for aneurysms and AVMs are improving, expanding the identified patient pool and supporting incremental procedure volume growth.

Geographic dynamics are shaping the distribution of market growth. Developing regions across Asia-Pacific, Latin America, and the Middle East are expected to contribute the most substantial unit volume increases as healthcare infrastructure and access to neurointerventional care expand. Developed markets in North America and Western Europe remain largely stable, with high baseline penetration rates limiting incremental demand. ASP pressure from competitive bidding and procurement consolidation is present across both market types, moderating market value growth relative to unit performance.

Market Drivers

Preference for Endovascular Techniques

The increasing acceptance of endovascular techniques over surgical procedures has been a primary driver of the neurovascular catheter market. Endovascular treatment for aneurysms and AVMs has become more popular than surgical alternatives such as clipping because the procedure is less invasive, safer for the patient, and typically associated with shorter recovery times. As this clinical preference strengthens and spreads to a broader range of physicians and institutions, more catheters will be required to support growing procedure volumes. The expansion of endovascular indications to include a wider range of aneurysm types and presentations is also broadening the patient population eligible for catheter-based treatment, supporting sustained unit volume growth across the forecast period.

Technological Advancement

Technological advancements in interventional navigational devices have been central to the broader shift toward endovascular treatment of AVMs and aneurysms. Guidewires have become easier to steer, and microcatheters continue to become smaller, more flexible, and easier to deploy. Improvements in physical properties, including better trackability, pushability, and torque response, allow catheters to navigate within regions of the brain that were not reachable with earlier generation products. As imaging technologies become more accurate and accessible, diagnosis rates for aneurysms and AVMs will continue to rise, requiring additional catheter-based procedures to treat the expanded patient population. The continued development of smaller, more capable catheter platforms is expected to reduce the need for surgical intervention and support ongoing conversion of cases toward endovascular approaches.

Market Limiters

Lack of Interventionalists

The number of trained neurological interventionalists available to perform endovascular neurovascular procedures is limited. These procedures require many years of specialized training and significant procedural experience before a physician can perform them consistently and safely. The limited supply of qualified interventionalists constrains the total number of catheter-dependent procedures that can be performed in any given market, placing a ceiling on procedure volume growth that is independent of patient demand or technology availability. An increase in the number of trained neurological interventionalists would be expected to directly increase microcatheter utilization, and efforts to expand training program capacity and referral pathways for endovascular therapy are therefore relevant to the long-term growth trajectory of this market.

Bias Towards Surgery

Despite the growing acceptance of endovascular access for neurological procedures, many older-generation neurosurgeons remain more comfortable with open surgical techniques they have used successfully throughout their careers. Physicians who are unfamiliar with the advantages of endovascular approaches are also less likely to refer patients for catheter-based therapy, further limiting case volumes in institutions where surgical mindset remains dominant. This limiter is expected to diminish progressively as younger, endovascular-trained physicians enter the workforce and as evidence supporting the clinical advantages of minimally invasive neurovascular treatment continues to accumulate. However, during the current forecast period it remains a relevant constraint on the pace of procedural volume growth in certain geographies and practice settings.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and technology trends shaping demand.
• Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
• Data sources: Primary interviews with neurovascular device industry leaders and neurointerventional physicians, regulatory data, hospital procurement data, import and export data, and the iData Research internal database.
• Care settings: Hospitals and neurovascular intervention centers.

Markets Covered and Segmentation

• The neurovascular catheter market is analyzed across three device type categories, each assessed by unit volume, ASP, and market value with historical and forecast data:
• Over-the-Wire Microcatheters
• Flow-Directed Microcatheters
• Neurovascular Guiding Catheters

Competitive Analysis

Terumo was the leader in the global neurovascular catheter market in 2025. The company's Sofia series of guiding catheters established its leading position in the total catheter market, with the Sofia platform recognized for its aspiration and delivery performance in the distal neurovascular space. Terumo's strength in the guiding catheter segment, where procedural volumes and per-unit values support strong market positioning, underpins its overall leadership across the combined catheter market.

Penumbra held the second-leading position in the global neurovascular catheter market in 2025. The company offers a broad product range within this segment, including the Benchmark 071 distal delivery catheter, the PX SLIM microcatheter, the Neuron system, and the Penumbra Select series. This portfolio provides coverage across both microcatheter and guiding catheter categories, allowing Penumbra to address multiple access and delivery requirements across a range of neurointerventional procedures. The company's established presence in stroke and neurovascular intervention supports its competitive positioning across all three catheter device types.

Medtronic was the third-leading competitor in the neurovascular catheter market in 2025. The company competes through its Echelon catheter, which is recognized for its tracking and usability properties, providing physicians with a reliable platform for navigation in complex cerebral anatomy. Medtronic's broader neurovascular portfolio, which spans guidewires, liquid embolics, and flow diverter platforms, supports cross-selling and clinical integration alongside its catheter product line.

Technology and Practice Trends

• Microcatheter miniaturization: Ongoing reductions in catheter diameter and profile are enabling access to more distal and tortuous cerebral vasculature, expanding the range of anatomically treatable cases.
• Improved trackability and pushability: Advances in catheter construction materials and shaft design are improving navigation performance in complex anatomy, reducing procedure time and the risk of vessel trauma.
• Flow-directed catheter evolution: Flow-directed microcatheters are benefiting from improvements in tip softness and flexibility that better leverage blood flow for distal navigation without guidewire support.
• Guiding catheter distal reach: Guiding catheter designs with improved distal support and aspiration capabilities are expanding their role in stroke thrombectomy and other high-demand neurointerventional applications.
• Imaging-driven diagnosis growth: Improving availability and accuracy of CT angiography and MRI is increasing the detection rate of aneurysms and AVMs, expanding the procedure population and supporting catheter unit demand.
• Developing market infrastructure expansion: Growing access to neurointerventional training and care in Asia-Pacific, Latin America, and the Middle East is expected to generate the most significant incremental unit volume growth over the forecast period.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• Where are the largest and fastest-growing opportunities across over-the-wire microcatheters, flow-directed microcatheters, and guiding catheters through 2032?
• How is the ongoing preference shift from open surgery to endovascular techniques driving catheter unit demand across aneurysm, AVM, and stroke indications?
• How are improvements in catheter miniaturization, trackability, and distal reach expanding the range of treatable anatomical targets?
• What are the implications of ASP pressure and competitive procurement on market value growth relative to unit volume performance?
• Which companies lead each catheter category and how are their product platforms differentiated across access, delivery, and aspiration applications?
• How do the limited supply of trained interventionalists and surgical preference bias constrain the pace of endovascular adoption across institutions and geographies?
• What is the outlook for developing market growth, and how do infrastructure and training dynamics shape regional demand patterns over the forecast period?
• What are the key risks to market growth, including pricing headwinds, the ceiling on surgical conversion, and the pace of interventionalist workforce expansion?

The Global Neurovascular Catheter Market Report from iData Research answers these questions with unit-level models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, and plan commercial strategy across a market where volume growth and technology advancement coexist with sustained pricing pressure.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Neurovascular Catheter Market

• 8.1 Executive Summary
  • 8.1.1 Global Neurovascular Catheter Market Overview
  • 8.1.2 Competitive Analysis
  • 8.1.3 Markets Included
  • 8.1.4 Regions Included
• 8.2 Introduction
• 8.3 Market Overview
  • 8.3.1 By Segment
  • 8.3.2 By Region
• 8.4 Market Analysis And Forecast
  • 8.4.1 Total Neurovascular Catheter Market
  • 8.4.2 Over-The-Wire Microcatheter Market
  • 8.4.3 Flow-Directed Microcatheter Market
  • 8.4.4 Neurovascular Guiding Catheter Market
• 8.5 Drivers And Limiters
  • 8.5.1 Market Drivers
  • 8.5.2 Market Limiters
• 8.6 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

• Chart 8-1: Neurovascular Catheter Market, Global, 2025 & 2032
• Chart 8-2: Neurovascular Catheter Units Sold, Global, 2025
• Chart 8-3: Neurovascular Catheter Market by Segment, Global, 2022 - 2032
• Chart 8-4: Neurovascular Catheter Market by Region, Global, 2022 - 2032
• Chart 8-5: Leading Competitors, Neurovascular Catheter Market, Global, 2025

LIST OF FIGURES

• Figure 8-1: Neurovascular Catheter Markets Covered
• Figure 8-2: Neurovascular Catheter Regions Covered, Global (1 of 2)
• Figure 8-3: Neurovascular Catheter Regions Covered, Global (2 of 2)
• Figure 8-4: Neurovascular Catheter Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 8-5: Neurovascular Catheter Market by Region, Global, 2022 - 2032 (US$M)
• Figure 8-6: Neurovascular Catheter Market, Global, 2022 - 2032
• Figure 8-7: Units Sold by Region, Neurovascular Catheter Market, Global, 2022 - 2032
• Figure 8-8: Average Selling Price by Region, Neurovascular Catheter Market, Global, 2022 - 2032 (US$)
• Figure 8-9: Market Value by Region, Neurovascular Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 8-10: Over-the-Wire Microcatheter Market, Global, 2022 - 2032
• Figure 8-11: Units Sold by Region, Over-the-Wire Microcatheter Market, Global, 2022 - 2032
• Figure 8-12: Average Selling Price by Region, Over-the-Wire Microcatheter Market, Global, 2022 - 2032 (US$)
• Figure 8-13: Market Value by Region, Over-the-Wire Microcatheter Market, Global, 2022 - 2032 (US$M)
• Figure 8-14: Flow-Directed Microcatheter Market, Global, 2022 - 2032
• Figure 8-15: Units Sold by Region, Flow-Directed Microcatheter Market, Global, 2022 - 2032
• Figure 8-16: Average Selling Price by Region, Flow-Directed Microcatheter Market, Global, 2022 - 2032 (US$)
• Figure 8-17: Market Value by Region, Flow-Directed Microcatheter Market, Global, 2022 - 2032 (US$M)
• Figure 8-18: Neurovascular Guiding Catheter Market, Global, 2022 - 2032
• Figure 8-19: Units Sold by Region, Neurovascular Guiding Catheter Market, Global, 2022 - 2032
• Figure 8-20: Average Selling Price by Region, Neurovascular Guiding Catheter Market, Global, 2022 - 2032 (US$)
• Figure 8-21: Market Value by Region, Neurovascular Guiding Catheter Market, Global, 2022 - 2032 (US$M)
• Figure 8-22: Leading Competitors, Neurovascular Catheter Market, Global, 2025